Taking beta blockers—a common drug regimen for patients with clinically stable coronary heart disease (SCHD)—likely does not have a benefit or outweigh these drugs’ risk for most patients, a University of Florida team report.
Source: www.hcplive.com
December 1, 2014 by 2012pharmaceutical
Taking beta blockers—a common drug regimen for patients with clinically stable coronary heart disease (SCHD)—likely does not have a benefit or outweigh these drugs’ risk for most patients, a University of Florida team report.
Source: www.hcplive.com
Leave a Reply